R Köhne-Volland

Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival

Max S. Topp, Peter Kufer, Nicola Gökbuget et al. · Journal of Clinical Oncology · 2011 · 902 citations · Full text

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

Max S. Topp, Nicola Gökbuget, Gerhard Zugmaier et al. · Blood · 2012 · 466 citations · Full text

Prophylaxis of Migraine with Oral Magnesium: Results From A Prospective, Multi-Center, Placebo-Controlled and Double-Blind Randomized Study

Andreas Peikert, C. Wilimzig, R Köhne-Volland · Cephalalgia · 1996 · 357 citations

Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study

Martin Reuther, EA Spottke, Jens Klotsche et al. · Parkinsonism & Related Disorders · 2006 · 101 citations

Quality Of Life, Prospective Longitudinal Study, Life Satisfaction +8

Cabergoline versus levodopa monotherapy: A decision analysis

A. Smala, EA Spottke, Olaf Machat et al. · Movement Disorders · 2003 · 16 citations